First Clinical Trial of Pluripotent Stem Cell-Derived Neural Stem Cells for Huntington’s Disease Highlighted at ISSCR 2026
Phase 1b/2a study marks an important milestone in the development of regenerative medicine approaches for Huntington's disease An update on the first clinical trial evaluating a pluripotent stem…
Read the full articleYou might also wanna read
The ISSCR Recognizes Outstanding Poster Award Winners at the ISSCR 2026 Annual Meeting in Montreal
ISSCR·9h ago
New Environmental Performance Index Highlights Sustainability Gains and the Challenges Ahead
cuimc.columbia.edu·1d ago
Pulse Security Debuts Operational Management Platform Built for Security Leaders
NextBigFuture·1d ago
Insignary Launches Clarity On-Demand: SBOMs, No Annual Commitment Required
NextBigFuture·1d ago
Nearly 500,000 Comments Submitted in Response to Trump Administration’s Proposal to Insert Politics into Federal Funding
environmentalprotectionnetwork.org·2d ago
Tego AI Finds Claude Tag Slack Integration Can Trigger Unauthorized Enterprise Actions
NextBigFuture·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.